{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T12:47:01Z","timestamp":1648990021865},"reference-count":19,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2018.1791","type":"journal-article","created":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T11:40:38Z","timestamp":1544701238000},"source":"Crossref","is-referenced-by-count":1,"title":["Complete remission of peritoneal dissemination of colon cancer by alternate\u2011day S\u20111 and oxaliplatin plus bevacizumab treatment and maintenance chemotherapy comprising alternate\u2011day S\u20111 plus bevacizumab: A case report"],"prefix":"10.3892","author":[{"given":"Nobuhiro","family":"Nitori","sequence":"first","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayu","family":"Kato","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Deguchi","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jumpei","family":"Nakadai","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Tada","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rumiko","family":"Umeda","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoteru","family":"Miyata","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikinori","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Kadomura","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotoshi","family":"Ebinuma","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kato","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hatori","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Center of Digestive Diseases, International University of Health and Welfare, Mita Hospital, Tokyo 108\u20118329, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,12,11]]},"reference":[{"key":"key20200713202255_b1-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.ejso.2013.10.001","article-title":"Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer","volume":"40","author":"van Gestel","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"key20200713202255_b2-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: A pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol"},{"key":"key20200713202255_b3-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.clcc.2015.12.006","article-title":"Bevacizumab in addition to palliative chemotherapy for patients with peritoneal carcinomatosis of colorectal origin: A nationwide population-based study","volume":"15","author":"Razenberg","year":"2016","journal-title":"Clin Colorectal Cancer"},{"key":"key20200713202255_b4-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/S1470-2045(13)70490-X","article-title":"Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): An open-label, non-inferiority, randomised phase 3 trial","volume":"14","author":"Yamada","year":"2013","journal-title":"Lancet Oncol"},{"key":"key20200713202255_b5-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/jjco\/hyn127","article-title":"Development history and concept of an oral anticancer agent S-1 (TS-1): Its clinical usefulness and future vistas","volume":"39","author":"Shirasaka","year":"2009","journal-title":"Jpn J Clin Oncol"},{"key":"key20200713202255_b6-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10147-004-0381-9","article-title":"Alternate-day oral therapy with TS-1 for advanced gastric cancer","volume":"9","author":"Arai","year":"2004","journal-title":"Int J Clin Oncol"},{"key":"key20200713202255_b7-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10147-008-0780-4","article-title":"Comparison of alternate-day versus consecutive-day treatment with S-1: Assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo","volume":"13","author":"Arai","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"key20200713202255_b8-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s10120-013-0289-z","article-title":"Feasibility study of alternate-day S-1 as adjuvant chemotherapy for gastric cancer: A randomized controlled trial","volume":"17","author":"Tatebe","year":"2014","journal-title":"Gastric Cancer"},{"key":"key20200713202255_b9-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1186\/1471-2407-14-883","article-title":"S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: Updated results from a phase 3 trial","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Cancer"},{"key":"key20200713202255_b10-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S1470-2045(12)70363-7","article-title":"S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: A randomised, non-inferiority phase 3 trial","volume":"13","author":"Hong","year":"2012","journal-title":"Lancet Oncol"},{"key":"key20200713202255_b11-mco-0-0-1791","first-page":"4004","article-title":"Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats","volume":"53","author":"Shirasaka","year":"1993","journal-title":"Cancer Res"},{"key":"key20200713202255_b12-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12885-015-1476-6","article-title":"Randomized phase II study of S-1 dosing schedule for resected colorectal cancer","volume":"15","author":"Matsuda","year":"2015","journal-title":"BMC Cancer"},{"key":"key20200713202255_b13-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1200\/JCO.2009.23.4344","article-title":"Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study","volume":"27","author":"Chibaudel","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20200713202255_b14-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1093\/annonc\/mdx322","article-title":"Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: Updated results and molecular subgroup analyses of the phase 3 CAIRO3 study","volume":"28","author":"Goey","year":"2017","journal-title":"Ann Oncol"},{"key":"key20200713202255_b15-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1200\/JCO.2007.10.7128","article-title":"Intergroup N9741: Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: Results from Intergroup N9741","volume":"25","author":"Dy","year":"2007","journal-title":"J Clin Oncol"},{"key":"key20200713202255_b16-mco-0-0-1791","first-page":"388","article-title":"Tumor marker CEA in monitoring of response to tegafur-uracil and folinic acid in patients with metastatic colorectal cancer","volume":"49","author":"Wang","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"key20200713202255_b17-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2214\/AJR.10.4687","article-title":"Diagnosis of peritoneal dissemination: Comparison of 18F-FDG PET\/CT, diffusion-weighted MRI, and contrast-enhanced MDCT","volume":"196","author":"Satoh","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"key20200713202255_b18-mco-0-0-1791","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1102\/1470-7330.2011.0016","article-title":"CT, MRI and PET imaging in peritoneal malignancy","volume":"11","author":"Patel","year":"2011","journal-title":"Cancer Imaging"},{"key":"key20200713202255_b19-mco-0-0-1791","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/DCR.0000000000000950","article-title":"Optimal surveillance protocols after curative resection in patients with stage IV colorectal cancer: A multicenter retrospective study","volume":"61","author":"Kishiki","year":"2018","journal-title":"Dis Colon Rectum"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:23:02Z","timestamp":1594668182000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2018.1791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,11]]},"references-count":19,"URL":"https:\/\/doi.org\/10.3892\/mco.2018.1791","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,11]]}}}